Wednesday, February 11, 2026

Goldman Sachs Forecasts Bullish Oil Market in 2021

Armed with the optimism of a successful COVID-19 vaccine by next year, Goldman Sachs has revised its forecast for the crude oil market, opting for a more bullish view for 2021.

According to analysts at Goldman Sachs, the oil market is expected to rebound as early as 2021, coinciding with the increasing likelihood of the availability of a coronavirus vaccine. The US bank predicts that international benchmark Brent will rise from $45 per barrel to $65 per barrel by the end of the end of the third quarter in 2021, before remaining steady at approximately $58 per barrel by the end of the year. Goldman Sachs also updated its forecast of $51.38 per barrel for West Texas Intermediate to $55.88 per barrel by the end of next year.

The analysts are also predicting that the global demand for oil will increase by 3.7 million barrels per day between January and August of 2021. However, irrespective of OPEC, the economic recovery for oil production will remain relatively subdued next year, especially for the US shale industry.

To date, OPEC members have agreed to maintain production cuts of 7.7 million barrels per day until the end of August due to impacts of continued limited demand. According to Reuters, compliance with the production cuts was relatively high at approximately 97% throughout the month of July.

Information for this briefing was found via Goldman Sachs and EIA. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Back to the Cariboo: Gold Rush History Meets Modern Discovery | Golden Caribou

Gold Prices Are High, Experience Matters | Rob McLeod

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

CareRx: Canaccord Raises Price Target To $6.50 Following Financing

Earlier this week, CareRx Corp (TSX: CRRX) closed their C$21.2 million bought deal. Notably, $6.25...

Friday, February 5, 2021, 11:45:00 AM

Pure Gold: Canaccord Suspends Rating After Operational Struggles

On Friday, Pure Gold Mining (TSXV: PGM) announced a number of updates for its investors....

Wednesday, April 27, 2022, 12:19:00 PM

Green Thumb: Analysts Upgrade Ratings On Back Of Earnings Beat

This morning Canaccord Genuity raised their 12-month price target on Green Thumb Industries (CSE: GTII)...

Thursday, November 12, 2020, 10:50:37 AM

Haywood Initiates Coverage On Cresco Labs With $14.00 Price Target

Last week, Haywood Securities initiated coverage on Cresco Labs (CSE: CL) with a C$14.00 price...

Wednesday, November 4, 2020, 01:59:00 PM

DraftKings: Consensus Estimates For Q1 2021

DraftKings (NASDAQ: DKNG) will be reporting its first quarter financial results on May 7th before...

Thursday, May 6, 2021, 05:17:00 PM